No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure

International Journal of Cardiology

Volumn 137, Issue 3, 2009, Pages 267-275

  Akashi, Yoshihiro J ^a   Palus, Sandra ^a   Datta, Rakesh ^b   Halem, Heather ^b   Taylor, John E ^b   Thoene Reineke, Christa ^a,c   Dong, Jesse ^b   Thum, Thomas ^d   Culler, Michael D ^b   Anker, Stefan D ^a   Springer, Jochen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Biomeasure Inc   (United States)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Body composition; Cachexia; Food intake; Ghrelin; Heart failure

Indexed keywords

CALCIUM ION; FUROSEMIDE; GHRELIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CACHEXIA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARDIAC CACHEXIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORONARY HEMODYNAMICS; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FLUID RETENTION; FOOD INTAKE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HORMONE RECEPTOR INTERACTION; INFUSION PUMP; LEAN BODY WEIGHT; LEFT CORONARY ARTERY; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; WEIGHT GAIN;

EID: 70749095878     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.094     Document Type: Article

References (28)

1. Kotler D.P., Tierney A.R., Wang J., and Pierson Jr. R.N. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50 (1989) 444-447
2. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
3. Farber M.O., and Mannix E.T. Tissue wasting in patients with chronic obstructive pulmonary disease. Neurol Clin 18 (2000) 245-262
4. Delano M.J., and Moldawer L.L. The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract 21 (2006) 68-81
5. Strassburg S., Springer J., and Anker S.D. Muscle wasting in cardiac cachexia. Int J Biochem Cell Biol 37 (2005) 1938-1947
6. Akashi Y.J., Springer J., and Anker S.D. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2 (2005) 198-203
7. Osterziel K.J., Strohm O., Schuler J., et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351 (1998) 1233-1237
8. Isgaard J., Bergh C.H., Caidahl K., Lomsky M., Hjalmarson A., and Bengtsson B.A. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J 19 (1998) 1704-1711
9. Anker S.D., Volterrani M., Pflaum C.D., et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38 (2001) 443-452
10. Cicoira M., Kalra P.R., and Anker S.D. Growth hormone resistance in chronic heart failure and its therapeutic implications. J Card Fail 9 (2003) 219-226
11. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
12. Nakazato M., Murakami N., Date Y., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
13. Nagaya N., Uematsu M., Kojima M., et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104 (2001) 2034-2038
14. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
15. Choi K., Roh S.G., Hong Y.H., et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144 (2003) 754-759
16. Nagaya N., Uematsu M., Kojima M., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 (2001) 1430-1435
17. Nagaya N., Moriya J., Yasumura Y., et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110 (2004) 3674-3679 Electronic publication 2004 Nov 3629
18. Thorsell A., Slawecki C.J., El Khoury A., Mathe A.A., and Ehlers C.L. The effects of social isolation on neuropeptide Y levels, exploratory and anxiety-related behaviors in rats. Pharmacol Biochem Behav 83 (2006) 28-34 Electonic publication 2006 Feb 2003
19. Philipp S., Jurgensen J.S., Fielitz J., et al. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats. Eur J Heart Fail 8 (2006) 347-354 Electronic publication 2006 Mar 2002
20. Toshinai K., Yamaguchi H., Sun Y., et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147 (2006) 2306-2314 Electronic publication 2006 Feb 2316
21. Hohimer A.R., Davis L.E., and Hatton D.C. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can J Physiol Pharmacol 83 (2005) 191-197
22. Maskali F., Franken P.R., Poussier S., et al. Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study. J Nucl Med 47 (2006) 337-344
23. Grossini E., Molinari C., Mary D.A., Ghigo E., Bona G., and Vacca G. Intracoronary ghrelin infusion decreases coronary blood flow in anesthetized pigs. Endocrinology 148 (2007) 806-812 Electronic publication 2006 Nov 2016
24. Anversa P., Loud A.V., Levicky V., and Guideri G. Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy. Am J Physiol 248 (1985) H876-H882
25. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
26. Baldanzi G., Filigheddu N., Cutrupi S., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159 (2002) 1029-1037 Electronic publication 2002 Dec 1016
27. Nagaya N., Kojima M., Uematsu M., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280 (2001) R1483-R1487
28. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150